How many patents does
Axikin Pharmaceuticals have?
patents
306
families
14
granted
60
applications
246
US
48
EP
28
WO
15
CN
13
JP
10
KR
9
RoW
183
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Axikin Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
| axikin pharmaceuticals | 258 |
| actimis pharmaceuticals | 13 |
| sma therapeutics | 3 |
| aixikin pharmaceutical | 1 |
| aktimis farmas'jutikalz | 1 |
| bayer healthcare | 1 |
2018
| sma therapeutics | 2 |
| axikin pharmaceuticals | 2 |
Axikin Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| 2,5-disubstituted arylsulfonamide ccr3 antagonists | 54 | 2009 |
| 3,5-diaminopyrazole kinase inhibitors | 37 | 2012 |
| arylsulfonamide ccr3 antagonists | 35 | 2009 |
| 2,5-disubstituted arylsulfonamide ccr3 antagonists | 35 | 2009 |
| 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the t… 🛈 | 30 | 2003 |
| pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors | 18 | 2013 |
| arylsulfonamide ccr3 antagonists | 17 | 2010 |
| 3,5-diaminopyrazole kinase inhibitors | 17 | 2014 |
| isotopically enriched arylsulfonamide ccr3 antagonists | 17 | 2012 |
| isotopically enriched arylsulfonamide ccr3 antagonists | 15 | 2010 |